BioStem Technologies prices $3 million at-the-market private placement under Nasdaq rules
BSEM•BioStem Technologies priced a $3 million private placement of 735,296 common shares at $4.08 each, with Series A and Series B warrants for 735,296 shares each. Full cash exercise of the warrants could raise an additional $5.6 million.
1. Placement details
The placement includes Series A and Series B warrants, each covering 735,296 shares and exercisable immediately at $3.83. Closing is expected September 30, 2026. BioStem plans to use the proceeds for working capital and general corporate purposes; H.C. Wainwright is the exclusive placement agent.
